# Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

> **NCT03427086** · PHASE2 · COMPLETED · sponsor: **American University of Beirut Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Biotin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03427086
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-29
- **Primary completion:** 2021-05-10
- **Final completion:** 2021-05-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427086, "Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03427086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*